Request Sample Inquiry
Biosensors Market

Biosensors Market

Biosensors Market - Global Industry Assessment & Forecast

Number Of Pages # Pages:

146

Base Year:

2021

Date

May - 2022

Format:

PDF XLS PPT

Report Code:

VMR-1600

Segments Covered
  • By Type Sensor Patch, Embedded Device
  • By Product Wearable Biosensors, Non-Wearable Biosensors
  • By Technology Electrochemical Biosensors, Optical Biosensors, Piezoelectric Biosensors, Thermal Biosensors, Nanomechanical Biosensors
  • By Application POC, Home Diagnostics, Research Labs, Environmental Monitoring, Food & Beverages, Biodefense
  • By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
Forecast YearsForecast Years: 2022 - 2028
Historical YearsHistorical Years: 2016 - 2021
Revenue 2021Revenue 2021: USD 25.1 Billion
Revenue 2028Revenue 2028: USD 38 Billion
Revenue CAGRRevenue CAGR (2022 - 2028): 7.2%
Fastest Growing Region Fastest Growing Region (2022 - 2028) Asia Pacific
Largest Region Largest Region (2021): North America
Customization Offered
  • Cross-segment Market Size and Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report
  • Go To Market Strategy
  • Region Specific Market Dynamics
  • Region Level Market Share
  • Import Export Analysis
  • Production Analysis
  • Others Request Customization Speak To Analyst
Biosensors Market Share

Global Biosensors Market

Biosensors Market- By Type, Product, Technology, Application, and Region.

Market Synopsis:

Global Biosensors Market is valued at USD 25.1 Billion in the year 2021 and is anticipated to reach a value of USD 38 Billion by the year 2028. The Global Market is forecasted to grow exhibiting a Compound Annual Growth Rate (CAGR) of 7.2% over the forecast period.

Biosensors Market Size, 2021 To 2028 (USD Billion)

The appearance of nanotechnology-based Biosensors, rising utilization of Biosensorss to monitor glucose levels in the individuals with diabetes, substantial technological advancements, rising government initiatives towards diagnostics, and the upsurging demand for home-based points of care devices owing to the coronavirus pandemic are the factors driving the growth of the Biosensors Market.

Furthermore, the surge in biotechnological research and development and the rising demand for home care devices are the other major factors that drive the Biosensors Market growth during the forecast period. Additionally, substantial growth in the preference for Biosensors in the glucose monitoring devices is majorly contributing to the growth of the Biosensors Market during the forecast period. The increasing geriatric population and the considerable rising chronic diseases are fueling the Biosensors Market growth during the forecast period.

Moreover, the increasing demand for point-of-care testing procedures is fueling the demand for effective Biosensors during the forecast period and will continue to grow in the upcoming years. Furthermore, the consumers are being advised to make use of Biosensors for regular detection of pathogenic activities in the body owing to the occurrence of chronic ailments which is expected to drive the Biosensors to demand in the coming years.

In addition, the Biosensors applications are expanding owing to the significant growth in the elderly demographics globally and the development of nanotechnology, which is increasing the affordability and availability of Biosensors during the forecast period. Whereas, the technological advancements in the Biosensors to make them portable and easy to handle are projected to create a profitable opportunity for the Biosensors Market growth in upcoming years. Besides, lack of inclination toward the adoption of new treatment devices, and the high cost associated with Biosensors devices are the major factors hampering the growth of the Biosensors Market during the forecast period.

Market Segmentation:

The Biosensors Market is segmented on the basis of type, product, technology, and application. Based on type, the market is segmented as Sensor Patch and Embedded Device. Based on product, the market is segmented as Wearable Biosensors and Non-wearable Biosensors . On the basis of technology, the market is segmented as Electrochemical Biosensors , Optical Biosensors , Piezoelectric Biosensors , Thermal Biosensors , and Nanomechanical Biosensors . Based on application, the market is segmented as POC, Home Diagnostics, Research Labs, Environmental Monitoring, Food & Beverages, and Biodefense.

Based on Type:

On the basis of type, the market is segmented as Sensor Patch and Embedded Device. The embedded devices are projected to acquire the largest share of the Biosensors Market during the forecast period. The embedded devices are widely used in various applications like home diagnostics, point of care, environmental monitoring, and food and beverages which is driving the embedded devices segment during the forecast period. Many healthcare facilities have started adopting embedded solutions for the medical devices permitted with IoT in order to address the lack of availability of doctors in remote areas.

Based on Product:

On the basis of product, the market is segmented into Wearable Biosensors and non-Wearable Biosensors. The wearable Biosensors are anticipated to grow at the highest Compound Annual Growth Rate (CAGR) during the forecast period. Wearable Biosensors have gained attention due to the potential to change the classical medical diagnostics and the constant health monitoring concepts which is driving the demand for wearable Biosensors during the forecast period. Additionally, the wearable Biosensors applications aim to transform the centralized hospital-based care systems into home-based personal medicine with the reduced cost and time for the diagnosis which is increasing the wearable Biosensors segment in the Biosensors Market. Furthermore, wearable Biosensors are distributing the wave of innovation in the society which is predicted to increase wearable Biosensors demand in the years to come.

North America is Projected to Acquire the Largest Share

North America is anticipated to acquire the largest share of the Biosensors Market during the forecast period. The factors that drive the overall growth of the Biosensors Market in North America include rising government funds for conducting research towards the growth of the advanced Biosensors for various applications. Moreover, the increase in the use of bio-sensors in North America for monitoring parameters of food quality is contributing to the growth of the North American Biosensors Market during the forecast period.

The Asia Pacific is Anticipated to Grow at the Highest Rate During the Forecast Period

Asia Pacific region is predicted to witness the highest growth in the Biosensors Market during the forecast period. The increasing incidences of chronic diseases and the presence of a large population base are the major factors driving the growth of the Biosensors Market in the Asia Pacific during the forecast period.

Competitive Landscape:

The key players in the Global Biosensors Market include- Abbott (US), Roche (Switzerland), Medtronic (Ireland), Bio-Rad Laboratories Inc. (US), DuPont (US), Biosensors International Group Ltd. (Singapore), CYTIVA (UK), Dexcom Inc. (US), LIFESCAN IP Holdings LLC (US), Masimo (US), Nova Biomedical (US), Universal Biosensors (Australia) and others.

Segmentation of the Global Biosensors Market:

Parameter Details
Segments Covered
  • Type (Sensor Patch, Embedded Device)
  • Product (Wearable Biosensors, Non-Wearable Biosensors)
  • Technology (Electrochemical Biosensors, Optical Biosensors, Piezoelectric Biosensors, Thermal Biosensors, Nanomechanical Biosensors)
  • Application (POC, Home Diagnostics, Research Labs, Environmental Monitoring, Food & Beverages, Biodefense)
  • Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa)
Regions & Countries Covered
  • North America - (U.S., Canada, Mexico)
  • Europe - (U.K., France, Germany, Italy, Spain, Rest Of Europe)
  • Asia Pacific - (China, Japan, India, South Korea, South East Asia, Rest Of Asia Pacific)
  • Latin America - (Brazil, Argentina, Rest Of Latin America)
  • Middle East & Africa - (GCC Countries, South Africa, Rest Of Middle East & Africa)
Companies Covered
  • Abbott (US)
  • Roche (Switzerland)
  • Medtronic (Ireland)
  • Bio-Rad Laboratories Inc. (US)
  • DuPont (US)
  • Biosensors International Group Ltd. (Singapore)
  • CYTIVA (UK)
  • Dexcom Inc. (US)
  • LIFESCAN IP Holdings LLC (US)
  • Masimo (US)
  • Nova Biomedical (US)
  • Universal Biosensors (Australia)
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, technology landscape, patent analysis, market attractiveness analysis by segments and North America, company market share analysis, and COVID-19 impact analysis

Biosensors Market to Reach Valuation of USD 38 Billion by 2028 - The Appearance of Nanotechnology-Based Biosensors, Rising Utilization of Bio-Sensors to Monitor Glucose Levels in the Individuals with Diabetes are Driving the Market Growth
In terms of revenue, the Global Biosensors Market is probable to reach USD 38 Billion by 2028, growing at a Compound Annual Growth Rate (CAGR) of 7.2% from 2022 to 2028. The substantial technological advancements, rising government initiatives towards diagnostics, and the upsurging demand for home-...
FAQ
Frequently Asked Question
  • The global Biosensors valued at USD 25.1 Billion in 2020 and is expected to reach USD 38 Billion in 2028 growing at a CAGR of 7.2%.

  • The prominent players in the market are Abbott (US), Roche (Switzerland), Medtronic (Ireland), Bio-Rad Laboratories Inc. (US), DuPont (US), Biosensors International Group Ltd. (Singapore), CYTIVA (UK), Dexcom Inc. (US), LIFESCAN IP Holdings LLC (US), Masimo (US), Nova Biomedical (US), Universal Biosensors (Australia).

  • The market is project to grow at a CAGR of 7.2% between 2021 and 2028.

  • The driving factors of the Biosensors include

    • Emergence of nanotechnology-based biosensors

  • North America was the leading regional segment of the Biosensors in 2020.